FDA Inspection 1041303 — The Magni Group, Inc.

The Magni Group, Inc. — FEI 3005317521

The FDA completed an inspection of The Magni Group, Inc. on February 7, 2018 in Mckinney, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 7, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Mckinney, TX (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
438921 CFR 211.198(a)Procedures to be written and followed